Gaxos.ai (GXAI) closed more than 40% higher today after Amazon Web Services (AWS) committed to funding preliminary development of its real-time sales coaching platform. The agreement named cloud services provider Caylent as partner and it focuses on developing Gaxos Labs — an enterprise-scale platform featuring live call transcription, automated coaching intelligence, and post-call analytics built on AWS-native infrastructure. More News from Barchart Following the post-announcement surge, GXAI stock is ...

Core Insights - Gaxos.ai Inc. has announced a partnership with Amazon Web Services (AWS) to develop an AI-powered sales coaching platform, which positions the company to compete in the multibillion-dollar sales technology market [2][4]. Group 1: Partnership and Development - AWS has committed to fund the preliminary development of Gaxos Labs' innovative platform, which is designed for enterprise-scale deployment and includes features such as live call transcription and automated coaching intelligence [3][4]. - The collaboration with Caylent, an AWS premier partner, focuses on building a fully AWS-native infrastructure that supports rapid scalability and operational efficiency [3][7]. Group 2: Strategic Implications - The partnership with AWS is seen as a major validation for Gaxos, enhancing its credibility and ability to pursue large-scale commercial opportunities [4]. - Gaxos anticipates that the AWS-supported development phase will lead to future revenue-generating opportunities and additional strategic partnerships [4]. Group 3: Company Background - Gaxos.ai is focused on developing AI applications across various sectors, including health, wellness, and gaming, aiming to redefine the human-AI relationship [8]. - Caylent specializes in cloud services, helping organizations modernize applications and build cloud-native platforms, with multiple awards recognizing its achievements in the AWS ecosystem [7].

Roseland, NJ, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced the official launch of Bible Pray AI, a personalized, AI-powered spiritual growth platform designed to help users deepen faith, strengthen daily devotion, and apply scripture for greater peace, clarity, and purpose. Bible Pray AI represents Gaxos’ strategic expansion into the rapidly growing digital faith, ment ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-41620 GAXOS.AI INC. (Exact name of registrant as specified in its charter) (Registrant's telephone number, incl ...

Company Participation - Gaxos.ai Inc. will participate in the WAWTech Conference on December 16-17, 2025, in Warsaw, Poland, focusing on artificial intelligence applications across high-growth sectors [1][2] Conference Overview - The WAWTech Conference is a significant tech event expected to attract over 5,000 IT professionals from Poland and Europe, featuring speakers from major global companies like Google, Agoda, and Netflix [3] Company Mission and Offerings - Gaxos.ai is dedicated to redefining the human-AI relationship, with applications in health, wellness, and gaming, aiming to address health, longevity, and entertainment through AI solutions [4]

Core Insights - Gaxos.ai Inc. has launched a new feature called Photoshoots for its Art-Gen platform, enhancing its capabilities in the AI-driven creator economy, which is projected to exceed $480 billion by 2027 [2][3] Company Overview - Gaxos.ai Inc. is focused on developing artificial intelligence applications across various high-growth sectors, including health, wellness, and gaming [7] Product Features - The Photoshoots feature allows users to create studio-quality images and animations quickly, transforming Art-Gen into a comprehensive visual studio [3] - Key features include professional photoshoot transformation, subject likeness preservation, optional creative direction, continuous iteration, instant animation, smart image transformation, one-click upscaling, dynamic video creation, AI prompt writer, style presets, and a live creative gallery [5]

Core Insights - Gaxos.ai Inc. has launched Art-Gen.AI, an AI image and video creation platform aimed at simplifying professional-grade content creation for users globally [1][2] - The generative AI market is projected to reach hundreds of billions of dollars in annual revenue over the next decade, positioning Gaxos to capture significant market share through a subscription-based model [2][3] Company Overview - Gaxos.ai is focused on developing AI applications across high-growth sectors, including health, wellness, and gaming, aiming to redefine the human-AI relationship [5] - The company emphasizes long-term value creation for shareholders by empowering creators and enterprises with advanced content production capabilities [3] Product Features - Art-Gen.AI offers features such as instant image and video generation from text prompts, smart image transformation, one-click upscaling, dynamic video creation, and an AI prompt writer [7] - The platform includes style presets for various visual themes and a live creative gallery for user inspiration [7]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-41620 GAXOS.AI INC. (Exact name of registrant as specified in its charter) Delaware 87-3288897 (State or other juris ...

Core Insights - Gaxos.ai Inc. has launched UnPGT.ai, a tool designed to enhance the naturalness of text generated by artificial intelligence, ensuring it sounds human-like without losing meaning or context [1][2] - UnPGT.ai utilizes a proprietary multi-pass transformation model that surpasses existing AI detection tools, addressing the growing demand for high-quality, undetectable outputs in sensitive sectors [2] Company Overview - Gaxos.ai Inc. is focused on redefining the human-AI relationship, with applications spanning health, wellness, and gaming, aiming to improve health, longevity, and entertainment through AI solutions [4] Product Features - UnPGT.ai includes several advanced features: - Adaptive Text Engine, which optimizes natural flow and allows for tone adjustments [6] - Contextual Synonym Intelligence, enhancing emotional tone, relevance, and clarity [6] - Seamless Web Integration, providing a browser extension for humanizing text across the web [6] - Recursive Refinement, which polishes text through multiple enhancement layers [6]

Revenue and Expenses - For the three months ended March 31, 2025, the company generated revenues of $23,732, primarily from RNK Health, which provided non-clinical services totaling $22,552[120]. - Operating expenses for the same period increased by $371,569, or 35.6%, totaling $1,415,427 compared to $1,043,858 in the prior year[121]. - General and administrative expenses totaled $1,194,438, reflecting an increase of $332,909, or 38.7%, compared to $861,529 in the previous year[123]. - Research and development fees rose to $220,989, an increase of $38,660, or 21.2%, primarily due to costs associated with Gaxos Health[122]. Net Loss and Cash Flow - The net loss for the three months ended March 31, 2025, was $1,232,062, an increase of $319,917, or 35.1%, from $912,145 in the same period of 2024[130]. - The company reported a loss from operations of $1,391,695 for the three months ended March 31, 2025, an increase of $347,856, or 33.3%[128]. - For the three months ended March 31, 2025, the net cash used in operations was $1,297,485, primarily due to a net loss of $1,232,062[134]. - For the three months ended March 31, 2024, the net cash used in operations was $1,099,417, resulting from a net loss of $912,145[135]. Investments and Financing - For the three months ended March 31, 2025, net cash used in investing activities was $10,529,274, mainly from the purchase of short-term investments of $12,171,293[136]. - The company sold 1,449,277 common shares at $3.45 per share in December 2024, generating net proceeds of $4,449,055[132]. - For the three months ended March 31, 2024, net cash provided by financing activities was $3,037,382, following a private placement of common stock and warrants[139]. Future Outlook and Plans - The company expects to continue generating operating losses in the foreseeable future due to corporate overhead and research and development costs[133]. - The company believes existing working capital will be sufficient to meet operating needs for the next twelve months[133]. - The company plans to pursue research and development of products, requiring additional capital from third-party sources[140]. Company Initiatives - The company launched Gaxos Labs in September 2024, focusing on generative AI services for game developers and publishers[109]. - Gaxos Health, initiated in 2024, aims to provide AI-powered health optimization solutions, integrating biometric data with personalized wellness strategies[111]. Accounting and Compliance - The company did not have any off-balance sheet arrangements for the three months ended March 31, 2025 and 2024[141]. - The company intends to rely on exemptions under the JOBS Act until certain revenue or debt thresholds are met[146]. - The company does not expect the adoption of new accounting standards to have a material impact on its consolidated financial statements[142].